Summary
This 8-K filing from AbbVie Inc. (ABBV) on July 27, 2018, primarily serves to furnish their press release announcing financial results for the second quarter ended June 30, 2018. While the 8-K itself doesn't contain detailed financial figures, it directs investors to the furnished press release (Exhibit 99.1) for comprehensive information on the company's operational and financial performance during the quarter. Investors should refer to this press release for specifics on revenue, earnings, guidance, and any other material financial data that would inform their investment decisions.
Key Highlights
- 1AbbVie Inc. (ABBV) filed an 8-K on July 27, 2018.
- 2The filing is related to the company's financial results for the second quarter ended June 30, 2018.
- 3The core of the filing is the furnishing of a press release (Exhibit 99.1) containing the Q2 2018 financial results.
- 4Investors are directed to the press release for detailed financial performance information.
- 5This filing acts as a notification and public dissemination of the company's quarterly performance update.
Frequently Asked Questions
The main purpose of this 8-K filing is to officially report AbbVie's financial results for the second quarter ended June 30, 2018, by furnishing the accompanying press release.
The detailed financial results for Q2 2018 are available in the press release, furnished as Exhibit 99.1 to this 8-K filing.
No, this 8-K filing itself does not contain the specific financial numbers. It references a press release (Exhibit 99.1) where those details can be found.
The event date is July 26, 2018, which is the date the press release announcing the financial results was likely prepared or finalized before its official filing on July 27, 2018.